Lincoln, Anne
Benton, Sally
Piggott, Carolyn
North, Bernard V.
Rigney, Jane
Young, Caroline
Quirke, Philip
Sasieni, Peter
Monahan, Kevin J. http://orcid.org/0000-0002-7918-4003
Funding for this research was provided by:
40tude Curing Colon Cancer Charity
Article History
Received: 28 February 2022
Accepted: 22 October 2022
First Online: 7 November 2022
Declarations
:
: This study has been approved by the Yorkshire & The Humber – Bradford Leeds Research Ethics Committee (21/YH/0066). At the time of writing, the study protocol version and date was: v5.0, dated 14th January 2022. The participating hospitals and study sites are: St Mark’s Hospital, London North West University Healthcare NHS Trust (Study Sponsor and Primary Site); King’s College London (coordinating centre); Newcastle Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust; Guy’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust; St George’s Hospital, St George’s University Hospitals NHS Foundation Trust; The Royal Marsden, The Royal Marsden NHS Foundation Trust; St Mary’s Hospital, Manchester University Hospitals NHS Foundation Trust; Birmingham Women’s and Children’s Hospital, Birmingham Women’s and Children’s NHS Trust; John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust; Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust; Bristol Royal Infirmary, University Hospital Bristol NHS Foundation Trust; Derriford Hospital, University Hospitals Plymouth NHS Trust; Ninewells Hospital and Medical School, University of Dundee NHS Tayside; NHS Bowel Cancer Screening South of England Hub (central lab); Leeds Institute of Medical Research’s Division of Pathology and Data Analytics, University of Leeds.
: Not applicable.
: Not applicable.